NextCure (NXTC) Accumulated Expenses (2018 - 2026)
NextCure (NXTC) posted quarterly Accumulated Expenses of $3.8 million for Q1 2026, up 27.2% year-over-year from $3.0 million in Q1 2025, and down 55.34% quarter-over-quarter from $8.6 million in Q4 2025.
NextCure (NXTC) Accumulated Expenses (2018 - 2026) Analysis & Trends
NextCure's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 27.2% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (up 27.2% YoY), while the FY2025 annual figure was $8.6 million, up 102.68% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.8 million, down from $8.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $8.6 million in Q3 2025, with the low at $3.0 million in Q1 2025.
- The 5-year median for Accumulated Expenses is $4.6 million (2023), against an average of $5.0 million.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 177.38% in 2022, then slumped 41.01% in 2025.
- NextCure's Accumulated Expenses stood at $4.9 million in 2022, then fell by 6.26% to $4.6 million in 2023, then slipped by 7.29% to $4.2 million in 2024, then surged by 102.68% to $8.6 million in 2025, then tumbled by 55.34% to $3.8 million in 2026.
- Business Quant data shows NXTC's Accumulated Expenses at $3.8 million in Q1 2026, $8.6 million in Q4 2025, and $8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.84 Mn |
| Mar 31, 2026 | 3.82 Mn |
| Dec 31, 2025 | 8.56 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 8.24 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 4.22 Mn |
| Sep 30, 2024 | 5.06 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | 3.95 Mn |
| Jun 30, 2023 | 5.01 Mn |
| Mar 31, 2023 | 4.35 Mn |
| Dec 31, 2022 | 4.86 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | 3.33 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 4.23 Mn |